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Rapid developments in molecular genetics, including the recent identification of two major breast cancer susceptibility genes (Miki et al., 1994; Wooster et al., 1995) have advanced understanding of the part played by familial factors in cancer risk. A family history is widely recognised as a powerful predictor of breast cancer (Steel et al., 1991) and is believed to account for at least 5% of all cases . These recent developments have been paralleled by a growth in services offering genetic counselling to individuals with a family history of breast cancer. Assessment of the psychological impact of these services and of subsequent participation in screening programmes has been advocated ; however, to date, little research has addressed these issues. Women at increased risk because of a family history of cancer may bear a heavy emotional burden (Wellisch et al., 1992; ) and a recent US evaluation of genetic counselling services suggested 27% of clinic attenders had levels of distress consistent with the need for psychological support . Results from a population-based study of high-risk women indicate that over a third suffer from significant levels of breast cancer-related worry (Lerman et al., 1993) .
The effectiveness of genetic counselling is very much dependent on attenders' comprehension of risk communications, the level of reassurance they may derive from counselling and their willingness to adhere to medical recommendations. The complexity of risk communication and risk perception in relation to health issues has been noted and attention may need to be directed to factors which facilitate comprehension and recall of risk estimations.
The present study set out to provide follow-up of attenders of two genetic counselling clinics. Ethical approval was obtained before commencement of the study. Cases were assessed at home and controls at the general practice, using standardised questionnaires which had good face validity, reliability and norms for specific reference populations.
Outcome measures Psychological morbidity The Brief Symptoms Inventory ) is a measure of psychological morbidity, selected on the basis that data have been collected on a similar sample of high-risk women and previous use in an evaluation of the psychological functioning of daughters of breast cancer patients (Wellisch et al., 1991) . Although norms for this measure are derived from American samples, it was selected primarily for comparison purposes.
The Impact of Event Scale was previously used as a measure of coping with response to a single traumatic event. This measure was adapted to gather information on cancer-specific distress . It provides indices on intrusive thoughts (level of preoccupation with breast cancer, 'I thought about it when I didn't mean to') and avoidance (use of denial as a coping strategy, 'I tried to remove it from memory'). An opt-out box was included for women who had not thought about breast cancer in the last week.
Risk perception (cases only) Derived from , this measure assessed retention of specific genetic risk information communicated at the clinic: (1) personal chances of breast cancer (1 in ... figure) ; (2) annual percentage chance of breast cancer; and (3) relative risk (chances compared with other women, i.e. average, above average, below average).
Early diagnostic behaviours Several reliable and prevalidated items which assessed specific health behaviours related to early detection: breast self-examination, mammography and clinical breast examination. However, controls were only asked about breast selfexamination, since it was unlikely that the majority of controls would have experience of mammography or regular clinical breast examination (only seven controls were over 50 years and eligible for the national screening programme). Additional items assessed use of hormone replacement therapy, uptake of cervical smears and participation in the tamoxifen trial in cases.
Health beliefs Included variables which, according to the health belief model , explain uptake of a preventative health behaviour: (1) barriers, perceived benefits and attitudes towards early diagnostic methods; (2) perceived severity of breast cancer; (3) cues to action (i.e. reminder methods).
Clinic evaluation An in-house scale (cases only). Items were included which assess the effectiveness of the clinics and covered benefits or otherwise of attendance, views on how reassuring the genetic consultation was felt to be and comments on action advised.
Statistical method Analyses were performed using the SPSS package. All tests between cases and controls incorporated the matched nature of the data. Parametric (paired t-test) or non-parametric (Wilcoxon matched pairs signed-rank test, McNemar's test, Kruskal-Wallis test) were used as appropriate for the nature and distribution of the data. One-tailed tests were used where a priori predictions were made about the direction of the differences between groups. All other tests were two-tailed. , 31% (95% CI 19%-43%) of cases and 34% (95% CI 22%-46%) of controls had levels of psychological symptoms consistent with the need for psychological counselling. Specific cancer distress, as assessed by the Impact of Event Scale, was significantly higher in cases than controls (see Table I ) on intrusion, avoidance and total score with 65% of cases and 16% of controls indicating that they had thought about breast cancer in the last 7 days.
Risk perception
A self-report item assessed women's perception of risk before clinic attendance. The majority of cases (58%) stated that they had overestimated their risk of breast cancer before genetic counselling, a further 32% stated that they had estimated their risk correctly and 10% reported that they had underestimated their risk.
Regarding post-clinic attendance, a total of 74% (95% CI 63% -85%) of cases rated themselves to be at 'above average' risk compared with 11% (95% CI 3%-19%) of controls when they estimated their chances of developing breast cancer relative to other women. Figure 1 illustrates the distribution of case and control responses in terms of Cases indicated the impact of the clinic on uptake of early diagnostic behaviour by comparing their rates of mammography, breast self-examination and clinical breast examination pre-clinic attendance with rates post-clinic. A total of 40% of cases reported increased rates of breast selfexamination following genetic clinic attendance (Table II) .
Other health behaviours (cases) Some 14.5% of cases were on hormone replacement therapy, 96.8% had had a cervical smear and 3.2% were participating in the tamoxifen trial.
Health beliefs Data on perceived barriers indicated that few difficulties existed in terms of cases monitoring their health in relation to their breasts (Table III) .
Attitude to mammography This was assessed by four attitude items (Table IV) . The majority of women disagreed with the statements 'mammograms cause unnecessary worry' and that 'mammograms expose women to excessive radiation'. In contrast, the statements 'regular screening means fewer deaths' and 'mammography reveals cancers before they can be felt' met with considerable agreement indicating a generally favourable attitude towards mammography in this sample.
Cases and controls were no different on items assessing perceived benefits of breast self-examination and were similarly confident in their own ability to carry out breast self-examination. Although barriers to self-examination were only measured by this single item, it is clear cases find the procedure difficult and some women commented to this effect as they were completing the questionnaire; for example, one remarked that she had had to stop examining her breasts as it made her anxious: every month she had thought 'is this the month that I will find a lump that will kill me?' Cases and controls universally perceived breast cancer to be a 'serious' disease.
The number of cases reminded by their doctors to have breast screening (cues to action) was 15%. Cases and controls were similar in terms of reading leaflets or having had a demonstration of breast self-examination, or being encouraged to perform the procedure by friends, a spouse, a doctor or nurse [although 29% (95% CI 16%-42%) of cases were more likely to report encouragement from 'other relatives' compared with 0% of controls]. Controls were far less likely than cases to have a reminder method for examining themselves [9% (95% CI 0.1%-17%) and 41% (95% CI 28% -54%) respectively].
Clinic evaluation Most clinic attenders reported that they found their consultation reassuring (79%). Of the rest, three individuals indicated that they found the clinic 'not reassuring' (5%) and a further 16% selected the 'neither' option. The majority of attenders found the consultation 'very or highly effective' (82%), with 15% considering it "somewhat effective' and only 3% saying that it was 'ineffective'. An open-ended question asked for brief comments about the benefits or otherwise of attending this clinic. The most common comment was that the clinic helped put attenders 'mind at rest'. Many women mentioned that they found it beneficial to receive information about breast cancer and their specific risks given their family history. Earlier access to mammograms and the opportunity to contribute to cancer research were also mentioned as beneficial.
Other results Other family members' counselling needs In all 71% of cases reported that they had other family members at risk of hereditary breast cancer and 34% had sent a copy of their clinic summary letter to relatives. Some 23% indicated that other family members had also attended the clinic.
Bereavement and adjustment to being at risk of hereditary cancer Relative to the general population this group of women is likely to have experienced considerably more bereavement. Not surprisingly, therefore, a proportion of women spontaneously mentioned such bereavement issues during the course of the interview, although this was not specifically assessed within our questionnaire. Two individuals had experienced their mother's death in the month before completing the questionnaire, and two others explained that they had terminally ill relatives and this may have influenced their responses. One woman who had had five female relatives die from breast cancer stated that she felt the clinic visit had been a traumatic experience and indicated that she would have welcomed an opportunity for some form of follow-up to enable her to express her grief. However, several women who had attended the clinic immediately after the death of a family member explained that they found the clinic helpful in the grieving process. Thus the clinic may have the potential to play a significant role in the emotional adjustment of women to their risk status and the bereavement they experience.
Criticism of and needs not addressed by the clinic One woman commented that she found the information too statistical. One commented that 'to them its just numbers, to me it's my life'. Another participant stated that although she found it beneficial to understand her relative chances of breast cancer she had not found clinic attendance helpful. Several women felt that there was not sufficient emphasis placed on action they could take regarding their risk. 'I don't want to think about the risks of cancer, I want to think about how I can prevent it'. Also mentioned were concerns about the roles of stress and diet in the development of cancer which receives less attention in consultations.
Discussion
We have examined current perception of risk, mental health, specific cancer worries and health beliefs in relation to risk management, in a group of women who attended for genetic counselling because of a family history of breast cancer. The inclusion of age-matched GP controls provided a reference population against which to compare these factors.
A striking and highly significant difference was apparent between counselled women and the GP control group in terms of cancer-specific distress, suggesting that high-risk women experience breast cancer-related worries that are not assuaged by genetic counselling. A more extensive prospective study is currently being conducted which should clarify this issue. High levels of cancer anxiety may reflect a sense of frustration that some women feel, once informed that they fall within a high-risk category, yet little may be offered to them in terms of primary prevention. Several women commented that, while they understood they had an increased risk of breast cancer, they had a less clear-cut picture of what they could do to manage that risk. Although no relationship was observed between the geneticist's risk figure and cancer distress, our data suggest that women's own perceptions of risk are associated with breast cancer worry.
Against initial predictions, counselled women and GP controls were similar on measures of general mental health, that is of primary importance. Clinic attendance appears to have influenced uptake of breast self-examination suggesting that, despite this being an unproven screening method, many high-risk women wish to do something themselves to help them manage their risk of breast cancer. It has also been argued that, since over 90% of breast cancers are found by women themselves, there is a need to optimise this method of detection . One of the most important benefits of genetic counselling is that women attending will subsequently take charge of their risk rather than feel helpless when their high-risk status is confirmed.
Future research
The recent cloning of the breast-ovarian cancer susceptibility gene (BRCA1), and a second breast cancer susceptibility gene (BRCA2), will have a considerable impact on genetic counselling services. Recent estimates suggest that as many as 1 in 800 women may carry a BRCA 1 mutation and potentially a large number of individuals may seek predictive DNA tests (Lerman et al., 1994; Watson et al., 1995) . It will become increasingly important to clarify which factors enhance ability to cope with high-risk status, and how best to provide appropriate psychological and medical support. A priority must be to investigate methods of communicating genetic risk information in order to clarify which methods are optimal, and greater account needs to be taken of women's prior expectation and beliefs about genetic inheritance and cancer.
